Following the issuance of a voluntary recall dated November 10, 2017 of one lot of NEXTERONE (amiodarone HCl) 150 mg/100 mL Premixed Injection, Baxter International Inc. announced today it is expanding the recall to include a second lot (NC109123) of NEXTERONE due to the potential presence of particulate matter.

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/baxter-expands-voluntary-nationwide-recall-include-second-lot-nexterone-injection-due-presence